{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:12:47Z","timestamp":1793304767932,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770809"],"award-info":[{"award-number":["81770809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673426"],"award-info":[{"award-number":["81673426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bethune-Merck Diabetes Research Foundation"},{"name":"Graduate Innovation Fund of Harbin Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetes cardiomyopathy (DCM) is a critical complication of long-term chronic diabetes mellitus and is characterized by myocardial fibrosis and myocardial hypertrophy. It has been suggested that DCM is related to pyroptosis, a programmed cell death associated with inflammation. The long non-coding RNA Kcnq1ot1 is involved in different pathophysiological mechanisms of multiple diseases, including acute myocardial damage and arrhythmia. Our previous study found that Kcnq1ot1 was elevated in left ventricular tissue of diabetic mice. However, whether Kcnq1ot1 is capable of regulating pyroptosis and fibrosis in high glucose-treated cardiac fibroblasts remains unknown. The aim of the study was to investigate the mechanisms of Kcnq1ot1 in DCM. Our study revealed that silencing Kcnq1ot1 by a lentivirus-shRNA improved cardiac function and fibrosis, ameliorated pyroptosis, and inhibited TGF-\u03b21\/smads pathway in C57BL\/6 mice. In vitro, experiments revealed that Kcnq1ot1 and pyroptosis were activated in cardiac fibroblasts treated with 30\u2009mmol\/l glucose. Furthermore, Kcnq1ot1 knockdown by a small interfering RNA decreased caspase-1 expression. Bioinformatic prediction and luciferase assays showed that Kcnq1ot1 functioned as a competing endogenous RNA to regulate the expression of caspase-1 by sponging miR-214-3p. In addition, silencing Kcnq1ot1 promoted gasdermin D cleavage and the secretion of IL-1\u03b2, thus repressing the TGF-\u03b21\/smads pathway in high glucose-treated cardiac fibroblasts through miR-214-3p and caspase-1. Therefore, Kcnq1ot1\/miR-214-3p\/caspase-1\/TGF-\u03b21 signal pathway presents a new mechanism of DCM progression and could potentially be a novel therapeutic target.<\/jats:p>","DOI":"10.1038\/s41419-018-1029-4","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T15:43:56Z","timestamp":1537803836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":242,"title":["Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy"],"prefix":"10.1038","volume":"9","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"1029_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina, S. & Abel, E. D. Diabetic cardiomyopathy, causes and effects. Rev. Endocr. Metab. Disord. 11, 31\u201339 (2010).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"1029_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","volume":"47","author":"J Asbun","year":"2006","unstructured":"Asbun, J. & Villarreal, F. J. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 47, 693\u2013700 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1029_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken, T., Fink, S. L. & Cookson, B. T. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7, 99\u2013109 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"1029_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","volume":"327","author":"K Schroder","year":"2010","unstructured":"Schroder, K., Zhou, R. & Tschopp, J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296\u2013300 (2010).","journal-title":"Science"},{"key":"1029_CR5","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.15252\/embj.201694696","volume":"35","author":"L Sborgi","year":"2016","unstructured":"Sborgi, L. et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 35, 1766\u20131778 (2016).","journal-title":"EMBO J."},{"key":"1029_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660\u2013665 (2015).","journal-title":"Nature"},{"key":"1029_CR7","doi-asserted-by":"publisher","first-page":"19571","DOI":"10.1074\/jbc.M114.550624","volume":"289","author":"NA Bracey","year":"2014","unstructured":"Bracey, N. A. et al. Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome. J. Biol. Chem. 289, 19571\u201319584 (2014).","journal-title":"J. Biol. Chem."},{"key":"1029_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2016.02.065","volume":"471","author":"P Jeyabal","year":"2016","unstructured":"Jeyabal, P. et al. MicroRNA-9 inhibits hyperglycemia induced cardiac pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem. Biophys. Res. Commun. 471, 423\u2013429 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1029_CR9","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","volume":"5","author":"X Li","year":"2014","unstructured":"Li, X. et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 5, e1479 (2014).","journal-title":"Cell Death Dis."},{"key":"1029_CR10","doi-asserted-by":"publisher","first-page":"e104771","DOI":"10.1371\/journal.pone.0104771","volume":"9","author":"B Luo","year":"2014","unstructured":"Luo, B. et al. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE 9, e104771 (2014).","journal-title":"PLoS ONE"},{"key":"1029_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10557-013-6498-1","volume":"28","author":"B Luo","year":"2014","unstructured":"Luo, B. et al. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc. Drugs Ther. 28, 33\u201343 (2014).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"1029_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","volume":"136","author":"CP Ponting","year":"2009","unstructured":"Ponting, C. P., Oliver, P. L. & Reik, W. Evolution and functions of long noncoding RNAs. Cell 136, 629\u2013641 (2009).","journal-title":"Cell"},{"key":"1029_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang, K. C. & Chang, H. Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904 (2011).","journal-title":"Mol. Cell"},{"key":"1029_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1515\/hsz-2017-0215","volume":"399","author":"X Gao","year":"2018","unstructured":"Gao, X., Ge, J., Li, W., Zhou, W. & Xu, L. LncRNA KCNQ1OT1 ameliorates particle-induced osteolysis through inducing macrophage polarization by inhibiting miR-21a-5p. Biol. Chem. 399, 375\u2013386 (2018).","journal-title":"Biol. Chem."},{"key":"1029_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2217\/epi-2017-0024","volume":"9","author":"E Coto","year":"2017","unstructured":"Coto, E. et al. Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT. Epigenomics 9, 1049\u20131057 (2017).","journal-title":"Epigenomics"},{"key":"1029_CR16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bbrc.2017.08.005","volume":"491","author":"X Li","year":"2017","unstructured":"Li, X. et al. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia\/reperfusion injury following acute myocardial infarction. Biochem. Biophys. Res. Commun. 491, 1026\u20131033 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1029_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000477330","volume":"42","author":"X Jin","year":"2017","unstructured":"Jin, X., Jin, H., Shi, Y., Guo, Y. & Zhang, H. Long non-coding RNA KCNQ1OT1 promotes cataractogenesis via miR-214 and activation of the caspase-1 pathway. Cell Physiol. Biochem. 42, 295\u2013305 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"1029_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00280-017-3356-z","volume":"80","author":"K Ren","year":"2017","unstructured":"Ren, K., Xu, R., Huang, J., Zhao, J. & Shi, W. Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma. Cancer Chemother. Pharmacol. 80, 243\u2013250 (2017).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1029_CR19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.18632\/aging.101418","volume":"10","author":"B Guo","year":"2018","unstructured":"Guo, B., Zhang, Q., Wang, H., Chang, P. & Tao, K. KCNQ1OT1 promotes melanoma growth and metastasis. Aging 10, 632\u2013644 (2018).","journal-title":"Aging"},{"key":"1029_CR20","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1073\/pnas.1422104112","volume":"112","author":"S Asahara","year":"2015","unstructured":"Asahara, S. et al. Paternal allelic mutation at the Kcnq1 locus reduces pancreatic beta-cell mass by epigenetic modification of Cdkn1c. Proc. Natl. Acad. Sci. USA 112, 8332\u20138337 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1029_CR21","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1101\/gad.1800909","volume":"23","author":"JE Wilusz","year":"2009","unstructured":"Wilusz, J. E., Sunwoo, H. & Spector, D. L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 23, 1494\u20131504 (2009).","journal-title":"Genes Dev."},{"key":"1029_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn, J. L. & Chang, H. Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145\u2013166 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"1029_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ni.1960","volume":"11","author":"EA Miao","year":"2010","unstructured":"Miao, E. A. et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11, 1136\u20131142 (2010).","journal-title":"Nat. Immunol."},{"key":"1029_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2174\/1874312901206010080","volume":"6","author":"CM Artlett","year":"2012","unstructured":"Artlett, C. M. The role of the NLRP3 inflammasome in fibrosis. Open Rheumatol. J. 6, 80\u201386 (2012).","journal-title":"Open Rheumatol. J."},{"key":"1029_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000351179","volume":"126","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Wu, Y., Chen, J., Zhao, S. & Li, H. Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation. Cardiology 126, 1\u201311 (2013).","journal-title":"Cardiology"},{"key":"1029_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000069328","volume":"70","author":"L Fern\u00e1ndez","year":"2002","unstructured":"Fern\u00e1ndez, L. & Mosquera, J. A. Interleukin-1 increases fibronectin production by cultured rat cardiac fibroblasts. Pathobiology 70, 191\u2013196 (2002).","journal-title":"Pathobiology"},{"key":"1029_CR27","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1093\/ndt\/gfp208","volume":"24","author":"DD Luo","year":"2009","unstructured":"Luo, D. D., Fielding, C., Phillips, A. & Fraser, D. Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling. Nephrol. Dial. Transplant. 24, 2655\u20132665 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1029_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1600-0560.2006.00584.x","volume":"34","author":"V Chaudhuri","year":"2007","unstructured":"Chaudhuri, V., Zhou, L. & Karasek, M. Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis. J. Cutan. Pathol. 34, 146\u2013153 (2007).","journal-title":"J. Cutan. Pathol."},{"key":"1029_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1083\/jcb.106.2.311","volume":"106","author":"AE Postlethwaite","year":"1988","unstructured":"Postlethwaite, A. E. et al. Modulation of fibroblast functions by interleukin-1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin-1 alpha and beta. J. Cell Biol. 106, 311\u2013318 (1988).","journal-title":"J. Cell Biol."},{"key":"1029_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-017-2968-2","volume":"428","author":"HJ Liu","year":"2017","unstructured":"Liu, H. J. et al. Apigenin alleviates STZ-induced diabetic cardiomyopathy. Mol. Cell Biochem. 428, 1\u201313 (2017).","journal-title":"Mol. Cell Biochem."},{"key":"1029_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000486357","volume":"45","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. Downregulation of long non-coding RNA Kcnq1ot1: an important mechanism of arsenic trioxide-induced long QT syndrome. Cell. Physiol. Biochem. 45, 192\u2013202 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"1029_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep23010","volume":"6","author":"Z Yang","year":"2016","unstructured":"Yang, Z. et al. Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGF\u03b21 and miR-29pathways. Sci. Rep. 6, 23010 (2016).","journal-title":"Sci. Rep."},{"key":"1029_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s13353-011-0055-z","volume":"52","author":"T Ma","year":"2011","unstructured":"Ma, T. et al. Microarray analysis of differentially expressed microRNAs in non-regressed and regressed bovine corpus luteum tissue; microRNA-378 may suppress luteal cell apoptosis by targeting the interferon gamma receptor 1 gene. J. Appl. Genet. 52, 481\u2013486 (2011).","journal-title":"J. Appl. Genet."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1029-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:19:25Z","timestamp":1671538765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1029-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1029-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1000"}}